Literature DB >> 10898078

Cryoglobulinemic vasculitis resistant to intermittent intravenous pulse cyclophosphamide therapy.

P Lamprecht1, A Gause, W L Gross.   

Abstract

We report on a 78-year-old patient with severe disease manifestations including polyneuropathy and clinically suspected secondary temporal arteritis due to hepatitis C virus-associated cryoglobulinemic vasculitis (CV). Despite intermittent intravenous pulse cyclophosphamide therapy and oral corticosteroid therapy her condition further deteriorated. Only oral cyclophosphamide therapy with high-dose corticosteroid and plasmapheresis was efficient in inducing a remission of her CV. This case report demonstrates that pulse cyclophosphamide therapy may not be sufficient to control severe manifestations of cryoglobulinemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898078     DOI: 10.1080/030097400750002139

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  1 in total

1.  A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide.

Authors:  Amira A Shahin; Soha M El Desouky; Hania S Zayed
Journal:  Clin Rheumatol       Date:  2010-10-06       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.